Daniel Rooks

Also affiliated with Novartis (United States)

MedicineBiochemistry, Genetics and Molecular BiologyHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium”.

Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium

Journal of the American Geriatrics Society(2020)10.1111/jgs.16372

N/A

0.973DataRank · unranked

655 citations

Thomas G. Travison, Todd M. Manini, Sheena Patel, Karol M. Pencina, Roger A. Fielding +24 more

Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force

The Journal of Frailty & Aging(2022)10.14283/jfa.2022.30

N/A

0DataRank · unranked

42 citations

Roberto Bernabei, Bruno Vellas, Roger A. Fielding, Daniel Rooks, Domenico Azzolino +5 more

Challenges and Future Prospects of Targeting Myostatin/Activin A Signaling to Treat Diseases of Muscle Loss and Metabolic Dysfunction

The Journals of Gerontology Series A(2023)10.1093/gerona/glad033

N/A

0DataRank · unranked

39 citations

Shalender Bhasin, Lloyd B. Klickstein, Venkatesh Krishnan, Daniel Rooks, Se‐Jin Lee